A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
Public ClinicalTrials.gov record NCT06741228. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Voyage
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized Anxiety Disorder - Voyage
Study identification
- NCT ID
- NCT06741228
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 11, 2024 (Actual)
- Primary completion
- Jul 15, 2026 (Actual)
- Completion
- Apr 2027 (Estimated)
- Last update posted
- Sep 25, 2026
2024 – 2027
United States locations
- U.S. sites
- 34
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lighthouse Psychiatry | Gilbert | Arizona | 85234 | — |
| Scottsdale Research Institute | Scottsdale | Arizona | 85022 | — |
| Kadima Neuropsychiatry Institute | La Jolla | California | 92037 | — |
| UCSF Department of Neurology | San Francisco | California | 94158 | — |
| Psychedelic Science Institute | Santa Monica | California | 90404 | — |
| Mountain View | Denver | Colorado | 80209 | — |
| Clinical Neuroscience Solutions Inc. | Jacksonville | Florida | 32256 | — |
| Segal Trials | Lauderhill | Florida | 33319 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| iResearch Atlanta | Decatur | Georgia | 30030 | — |
| CenExel iResearch, LLC | Savannah | Georgia | 31405 | — |
| Uptown Research Institute | Chicago | Illinois | 60640 | — |
| Adams Clinical Boston | Boston | Massachusetts | 02116 | — |
| Adams Clinical Watertown | Watertown | Massachusetts | 02472 | — |
| Hassman Research Institute | Marlton | New Jersey | 08053 | — |
| Spectrum Neuroscience and Treatment Institute | New York | New York | 10021 | — |
| Adams Clinical Harlem | New York | New York | 10029 | — |
| New York State Psychiatric Institute (NYSPI) | New York | New York | 10032 | — |
| Adams Clinical Bronx | The Bronx | New York | 10461 | — |
| Cleveland Clinic Lutheran Hospital | Cleveland | Ohio | 44113 | — |
| Summit Headlands LLC | Portland | Oregon | 97210 | — |
| Scranton Medical Institute | Moosic | Pennsylvania | 18507 | — |
| Adams Clinical Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Coastal Carolina Research Center | North Charleston | South Carolina | 29405 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| University of Texas at Austin | Austin | Texas | 78712 | — |
| Austin Clinical Trial Partners | Austin | Texas | 78737 | — |
| BioBehavioral Research of Austin | Austin | Texas | 78759 | — |
| FutureSearch Trials of Dallas, LLC | Dallas | Texas | 75231 | — |
| Adams Clinical Dallas | DeSoto | Texas | 75115 | — |
| Cedar Clinical Research | Draper | Utah | 84020 | — |
| Inner Space Research | Orem | Utah | 84058 | — |
| Memory Clinic Inc. | Bennington | Vermont | 05201 | — |
| Seattle Neuropsychiatric Treatment Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06741228, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06741228 live on ClinicalTrials.gov.